Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioavailability of Two Formulations of Eszopiclone 3.0 mg Coated Tablets With Regards to the Marketed Reference Product

NCT05349396 is registered in ClinicalTrials.gov with Laboratorios Andromaco S.A. as lead sponsor.

NCT NCT05349396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05349396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioavailability of Two Formulations of Eszopiclone 3.0 mg Coated Tablets With Regards to the Marketed Reference Product
Lead sponsor
Laboratorios Andromaco S.A.
Phase
Phase 1
Overall status
Completed
Start date
April 11, 2022
Completion date
April 19, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence